568 related articles for article (PubMed ID: 17591654)
1. Low dose ketamine: a therapeutic and research tool to explore N-methyl-D-aspartate (NMDA) receptor-mediated plasticity in pain pathways.
Chizh BA
J Psychopharmacol; 2007 May; 21(3):259-71. PubMed ID: 17591654
[TBL] [Abstract][Full Text] [Related]
2. [Low doses ketamine: antihyperalgesic drug, non-analgesic].
Richebé P; Rivat C; Rivalan B; Maurette P; Simonnet G
Ann Fr Anesth Reanim; 2005; 24(11-12):1349-59. PubMed ID: 16115745
[TBL] [Abstract][Full Text] [Related]
3. Prolonged analgesic effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain.
Rabben T; Skjelbred P; Oye I
J Pharmacol Exp Ther; 1999 May; 289(2):1060-6. PubMed ID: 10215688
[TBL] [Abstract][Full Text] [Related]
4. NMDA receptor antagonists and pain: ketamine.
Muir WW
Vet Clin North Am Equine Pract; 2010 Dec; 26(3):565-78. PubMed ID: 21056300
[TBL] [Abstract][Full Text] [Related]
5. [The role of the NMDA-receptor blocker and stimulator ketamine and glycine in the development of a neuropathic pain syndrome].
Danilova EI; Grafova VN; Reshetniak VK
Eksp Klin Farmakol; 1997; 60(4):10-3. PubMed ID: 9376747
[TBL] [Abstract][Full Text] [Related]
6. Depression of NMDA-receptor-mediated segmental transmission by ketamine and ketoprofen, but not L-NAME, on the in vitro neonatal rat spinal cord preparation.
Lizarraga I; Chambers JP; Johnson CB
Brain Res; 2006 Jun; 1094(1):57-64. PubMed ID: 16716267
[TBL] [Abstract][Full Text] [Related]
7. The antiallodynic effect of NMDA antagonists in neuropathic pain outlasts the duration of the in vivo NMDA antagonism.
Christoph T; Schiene K; Englberger W; Parsons CG; Chizh BA
Neuropharmacology; 2006 Jul; 51(1):12-7. PubMed ID: 16616769
[TBL] [Abstract][Full Text] [Related]
8. [NMDA-receptor antagonist in pain therapy].
Weber C
Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Aug; 33(8):475-83. PubMed ID: 9746842
[TBL] [Abstract][Full Text] [Related]
9. Ketamine in cancer pain: an update.
Mercadante S
Palliat Med; 1996 Jul; 10(3):225-30. PubMed ID: 8817593
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic N-methyl-D-aspartate receptor antagonists: will reality meet expectation?
Smith PF
Curr Opin Investig Drugs; 2003 Jul; 4(7):826-32. PubMed ID: 14619404
[TBL] [Abstract][Full Text] [Related]
11. The NMDA receptor complex: a long and winding road to therapeutics.
Wood PL
IDrugs; 2005 Mar; 8(3):229-35. PubMed ID: 15772895
[TBL] [Abstract][Full Text] [Related]
12. Glutamate-based therapeutic approaches: NR2B receptor antagonists.
Gogas KR
Curr Opin Pharmacol; 2006 Feb; 6(1):68-74. PubMed ID: 16376149
[TBL] [Abstract][Full Text] [Related]
13. The chemical biology of clinically tolerated NMDA receptor antagonists.
Chen HS; Lipton SA
J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
[TBL] [Abstract][Full Text] [Related]
14. Ketamine*.
Quibell R; Prommer EE; Mihalyo M; Twycross R; Wilcock A
J Pain Symptom Manage; 2011 Mar; 41(3):640-9. PubMed ID: 21419322
[No Abstract] [Full Text] [Related]
15. Effects of ketamine on acute somatic nociception in wild-type and N-methyl-D-aspartate (NMDA) receptor epsilon1 subunit knockout mice.
Petrenko AB; Yamakura T; Askalany AR; Kohno T; Sakimura K; Baba H
Neuropharmacology; 2006 May; 50(6):741-7. PubMed ID: 16427663
[TBL] [Abstract][Full Text] [Related]
16. Role of N-methyl-D-aspartate receptor antagonists in postoperative pain management.
Suzuki M
Curr Opin Anaesthesiol; 2009 Oct; 22(5):618-22. PubMed ID: 19535974
[TBL] [Abstract][Full Text] [Related]
17. Nonselective and NR2B-selective N-methyl-D-aspartic acid receptor antagonists produce antinociception and long-term relief of allodynia in acute and neuropathic pain.
Swartjes M; Morariu A; Niesters M; Aarts L; Dahan A
Anesthesiology; 2011 Jul; 115(1):165-74. PubMed ID: 21606828
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of action of memantine.
Johnson JW; Kotermanski SE
Curr Opin Pharmacol; 2006 Feb; 6(1):61-7. PubMed ID: 16368266
[TBL] [Abstract][Full Text] [Related]
19. Systems biology approaches for toxicology.
Slikker W; Paule MG; Wright LK; Patterson TA; Wang C
J Appl Toxicol; 2007; 27(3):201-17. PubMed ID: 17265419
[TBL] [Abstract][Full Text] [Related]
20. Effects of pan- and subtype-selective N-methyl-D-aspartate receptor antagonists on cortical spreading depression in the rat: therapeutic potential for migraine.
Peeters M; Gunthorpe MJ; Strijbos PJ; Goldsmith P; Upton N; James MF
J Pharmacol Exp Ther; 2007 May; 321(2):564-72. PubMed ID: 17267580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
